Compare Arkham (ARKM) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arkham vs Mira — how do they compare? Arkham trades at Rp1,637 (market cap Rp370,03M, Rp1,28T 24h volume), while Mira trades at Rp698.2 (market cap Rp224,51M, Rp102,44M 24h volume). The key difference: Arkham is the larger of the two by market cap, and Arkham's circulating supply is 225,1M / 1B ARKM (23%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Arkham for 51 Days and Mira for 22 Days on average.
| ARKM | MIRA | |
|---|---|---|
Market Cap | Rp370,03M | Rp224,51M |
Volume (24h) | Rp1,28T | Rp102,44M |
Circulating Supply | 225,1M / 1B ARKM (23%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 51 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKM is trading at Rp1,669, showing a bearish technical outlook with moving averages signaling strong selling pressure and oscillators neutral. The current price is near the pivot point of Rp1,670, with immediate support at Rp1,641 and resistance at Rp1,698. No major protocol updates or ecosystem developments were noted recently, with a circulating supply of 225.1 million ARKM out of a 1 million max supply, indicating a 23% circulation rate.
The overall outlook is cautious due to bearish technical signals and limited fundamental catalysts. Key opportunities include potential rebounds from support levels, but risks involve high volatility, low liquidity, and regulatory uncertainties in the crypto space. Investors should monitor trading volume and on-chain activity for signs of recovery.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Arkham
Arkham is a blockchain analysis platform that uses artificial intelligence to deanonymize the blockchain and on-chain data. Arkham’s platform can be used for various purposes, such as tracking stolen funds, identifying fraudsters, verifying counterparties, auditing transactions, investigating hacks, and more. Arkham claims its platform can help combat the proliferation of crypto crimes and scams by incentivizing on-chain research.
Read more on ARKM →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
